ID
35198
Description
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the subjects laboratory tests and should be filled out at Visit 1, 6 (liver tests only) , 8, EW, Day 7 Follow Up, Day 14 Follow Up. Laboratory tests are mandatory at Day 7 FU visit except where Day 7 FU follows Early Withdrawal Visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Keywords
Versions (2)
- 2/24/19 2/24/19 -
- 11/10/19 11/10/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
February 24, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Laboratory Tests
- StudyEvent: ODM
Description
Haematology
Alias
- UMLS CUI-1
- C0018941
Description
Clinical Chemistry
Alias
- UMLS CUI-1
- C0008000
Description
Urinalysis
Alias
- UMLS CUI-1
- C0042014
Similar models
Laboratory Tests
- StudyEvent: ODM
C2985720 (UMLS CUI [1,2])